High Insider Ownership Growth Companies On US Exchanges In July 2024

The U.S. stock market continues its upward trajectory, with major indices like the S&P 500 and Nasdaq Composite reaching record highs, driven by robust performances in the technology sector. In this environment, companies with high insider ownership can be particularly interesting, as significant insider stakes often align leadership’s interests with those of shareholders, potentially leading to more sustainable growth amidst these optimistic market conditions.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
GigaCloud Technology (NasdaqGM:GCT)	25.9%	21.3%
PDD Holdings (NasdaqGS:PDD)	32.1%	23.3%
Atour Lifestyle Holdings (NasdaqGS:ATAT)	26%	22.1%
Bridge Investment Group Holdings (NYSE:BRDG)	11.6%	98.2%
Duolingo (NasdaqGS:DUOL)	15%	48.1%
Super Micro Computer (NasdaqGS:SMCI)	14.3%	40.1%
Credo Technology Group Holding (NasdaqGS:CRDO)	14.7%	60.9%
Carlyle Group (NasdaqGS:CG)	29.2%	23.6%
EHang Holdings (NasdaqGM:EH)	32.8%	74.3%
BBB Foods (NYSE:TBBB)	22.9%	94.7%

Click here to see the full list of 178 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's dive into some prime choices out of from the screener.

Corcept Therapeutics (NasdaqCM:CORT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Corcept Therapeutics Incorporated focuses on the discovery and development of drugs for severe endocrinologic, oncologic, metabolic, and neurologic disorders in the U.S., with a market capitalization of approximately $3.11 billion.

Operations: The company generates its revenue primarily from the discovery, development, and commercialization of pharmaceutical products, totaling approximately $523.53 million.

Insider Ownership: 11.3%

Corcept Therapeutics, a growth-oriented company with high insider ownership, recently added to the Russell 2000 Dynamic Index, demonstrates robust involvement in clinical advancements and financial activities. Noteworthy is their successful Phase 3 trial of relacorilant for Cushing’s syndrome, indicating significant medical potential. Financially, Corcept has been active in equity offerings linked to employee stock ownership plans totaling over US$249.68 million and reported a substantial increase in Q1 earnings from US$15.88 million to US$27.76 million year-over-year. Despite these positives, shareholder dilution has occurred over the past year, which may concern some investors about potential value erosion.

• Delve into the full analysis future growth report here for a deeper understanding of Corcept Therapeutics.
• Our valuation report here indicates Corcept Therapeutics may be undervalued.

Amazon.com (NasdaqGS:AMZN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Amazon.com, Inc. operates globally, offering consumer products, advertising services, and subscriptions through its online and physical stores, with a market capitalization of approximately $2.07 trillion USD.

Operations: The company generates revenue through its segments, with North America contributing $362.29 billion, International sales at $134.01 billion, and Amazon Web Services (AWS) earning $94.44 billion.

Insider Ownership: 10.8%

Amazon.com stands out in the growth company landscape with its impressive earnings growth of 777.6% over the past year and expectations for continued expansion at a rate of 21.31% per annum. Trading 35.1% below estimated fair value, it offers potential value despite a forecasted low return on equity of 18.1% in three years. Recent collaborations, like expanding Exscientia’s AI-driven drug discovery using AWS, highlight Amazon's strategic use of cutting-edge technology to foster growth and innovation across various sectors.

• Dive into the specifics of Amazon.com here with our thorough growth forecast report.
• Our valuation report unveils the possibility Amazon.com's shares may be trading at a premium.

Palantir Technologies (NYSE:PLTR)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Palantir Technologies Inc. develops software platforms for the intelligence community to support counterterrorism efforts in the U.S., the U.K., and globally, with a market capitalization of approximately $60.99 billion.

Operations: The company generates revenue from two primary segments: Commercial, which brought in $1.07 billion, and Government, contributing $1.27 billion.

Insider Ownership: 13.5%

Palantir Technologies, a key participant in the high insider ownership and growth company sector, has recently secured significant contracts and strategic alliances that underscore its expanding influence in data analytics and AI platforms. Notably, Palantir's collaboration with Oracle enhances its AI capabilities across government and defense sectors, while a US$19 million deal with ARPA-H aims to accelerate health outcomes. Despite these advances, shareholder dilution over the past year raises concerns. The company's revenue is projected to grow at 15.9% annually, outpacing the US market average of 8.8%, yet its return on equity remains modest at 17%.

• Navigate through the intricacies of Palantir Technologies with our comprehensive analyst estimates report here.
• Our expertly prepared valuation report Palantir Technologies implies its share price may be too high.

Turning Ideas Into Actions

• Dive into all 178 of the Fast Growing US Companies With High Insider Ownership we have identified here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com